
Dr. Sanjeev Kumar Sharma is a senior Haematologist and Bone Marrow Transplant specialist serving as Director – Haematology, Haemato-Oncology and Bone Marrow Transplant at Max Healthcare's BLK-Max Super Speciality Hospital, New Delhi. With more than 19 years of professional experience, he specialises in the diagnosis and management of blood disorders and conditions requiring stem cell transplantation.
He completed his MBBS, followed by an MD in Medicine and DM in Clinical Haematology. His specialist clinical training has included residency in Haematology at AIIMS, New Delhi, and Internal Medicine and Haematology at PGIMER, Chandigarh.
His clinical areas of expertise include haematological disorders, haemato-oncology and bone marrow transplantation. His specialist practice focuses on the evaluation and management of complex blood-related conditions requiring advanced haematological treatment and transplant-based care.
Dr. Sharma has also worked at the Regional Blood Transfusion Centre at GTB Hospital and the Department of Burns and Plastic Surgery at Guru Teg Bahadur Hospital, Delhi. His professional recognitions include the Best Citizen of India Award in 2014 and a Gold Medal for his MD thesis presentation. He is associated with the Indian Society of Haematology and Blood Transfusion and the Delhi Medical Association.
Decades of expertise, proven results, and compassionate care — here is why patients from 50+ countries trust Dr. Sanjeev Kumar Sharma for Haemato-Oncology & BMT treatment in India.
Over 20 years of dedicated clinical experience with 5,000+ procedures. One of the most trusted names in Haemato-Oncology & BMT in India.
Dr. Sanjeev Kumar Sharma regularly treats patients from Africa, the Middle East, Central Asia, and Europe. Dedicated international patient support team available 24/7.
Practices at an internationally accredited hospital, ensuring patient safety standards that match the best hospitals in the USA and Europe.
World-class treatment at a fraction of USA, UK, or Australian prices. Transparent cost estimates provided before you travel.
Dr. Sanjeev Kumar Sharma holds postgraduate qualifications from premier Indian institutions and has advanced fellowship training in DM (Clinical Haematology)
Every case is personally reviewed. Treatment plans are tailored, transparent, and discussed in detail before you make any decisions or travel arrangements.
Intensive induction, consolidation, and maintenance chemotherapy with BMT for eligible patients.
Tyrosine kinase inhibitor therapy for CML; chemoimmunotherapy and targeted agents for CLL.
Multi-agent chemotherapy with or without radiotherapy; autologous or allogenic transplant for relapsed disease.
Novel agent-based regimens, autologous stem cell transplant, and maintenance therapy for myeloma.
Immunosuppressive therapy (IST) or allogenic BMT as definitive curative treatment.
Hypomethylating agents, supportive care, and allogenic BMT for high-risk MDS.
Cytoreductive therapy, JAK inhibitors, and BMT for MF/PV/ET and related conditions.
Comprehensive evaluation and transplant-based or non-transplant management of BMF.
Curative allogenic BMT for thalassaemia major and sickle cell disease in eligible patients.
Allogenic BMT from matched sibling, matched unrelated, or haploidentical donors.
High-dose chemotherapy followed by autologous stem cell rescue for eligible haematological malignancies.
Chimeric antigen receptor T-cell therapy for relapsed/refractory B-cell malignancies.
Evidence-based systemic therapy for all haematological malignancies.
Efficient peripheral blood stem cell collection for autologous and haploidentical transplants.
Send your medical reports and get a personalised treatment plan. The team reviews cases from 50+ countries and responds within 24 hours.
Our team responds within 24 hours
Share your reports and receive a personalised treatment recommendation within 48 hours — at no cost.